dabigatran has been researched along with irinotecan in 4 studies
Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (irinotecan) | Trials (irinotecan) | Recent Studies (post-2010) (irinotecan) |
---|---|---|---|---|---|
3,887 | 261 | 3,490 | 8,002 | 1,885 | 3,752 |
Protein | Taxonomy | dabigatran (IC50) | irinotecan (IC50) |
---|---|---|---|
Solute carrier family 22 member 2 | Homo sapiens (human) | 2.7 | |
Interstitial collagenase | Homo sapiens (human) | 6.06 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 1.556 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 3.171 | |
Acetylcholinesterase | Homo sapiens (human) | 1.827 | |
Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 7.9 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 4.7667 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
Merali, Z; Paré, G; Ross, S | 1 |
Akiyoshi, T; Hattori, T; Imaoka, A; Ohtani, H | 1 |
Ip, CM; Ji, X; Lai, YS; Ng, WL; Song, Q; Xiao, M; Zhang, J; Zhang, Y; Zuo, Z | 1 |
1 review(s) available for dabigatran and irinotecan
Article | Year |
---|---|
The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Aspirin; Benzimidazoles; Camptothecin; Carboxylesterase; Carboxylic Ester Hydrolases; Central Nervous System Stimulants; Clopidogrel; Dabigatran; Factor Xa Inhibitors; Genotype; Humans; Imidazolidines; Irinotecan; Isoenzymes; Methylphenidate; Oseltamivir; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Pyridines; Ticlopidine | 2014 |
3 other study(ies) available for dabigatran and irinotecan
Article | Year |
---|---|
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Irinotecan-induced gastrointestinal damage impairs the absorption of dabigatran etexilate.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Dabigatran; Gastrointestinal Diseases; Intestinal Absorption; Intestinal Mucosa; Irinotecan; Male; Partial Thromboplastin Time; Rats | 2019 |
Inhibition of Radix Scutellariae flavones on carboxylesterase mediated activations of prodrugs.
Topics: Animals; Carboxylesterase; Dabigatran; Flavones; Irinotecan; Molecular Docking Simulation; Prodrugs; Rats; Scutellaria; Scutellaria baicalensis | 2022 |